Evaluating the Efficacy of Premedication in Preventing Hypersensitivity Reactions to Nonionic Contrast Agents
Biological and Pharmaceutical Bulletin · 2025
DOI: 10.1248/bpb.b24-00808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Shinya Suzuki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experiential Pharmacy Practice, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192…. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Contrast Media, Premedication, Iodine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Iodine-based contrast agents can induce various acute hypersensitivity reactions ranging from mild itching or vomiting shortly after administration to severe hypotension or loss of consciousness. In Japan, steroid premedication is commonly used to prevent acute hypersensitivity reactions. However, little clear evidence supporting its efficacy is available. In this study, we evaluated the effectiveness of premedication for acute hypersensitivity reactions induced by nonionic iodine contrast agents using propensity score matching. The participants included patients who were administered nonionic iodine contrast agents at Yokohama City Minato Red Cross Hospital between April 1, 2016 and March 31, 2022. Only first-time patients with no history of hypersensitivity reactions to contrast agents were included. The patients were classified into premedication and non-premedication groups, and the incidence proportions of acute hypersensitivity reactions were compared after matching. Of the 19976 patients, 422 (211 in each group) were matched. In the premedication group, 7 cases (3.32%) of hypersensitivity reactions occurred. In contrast, only 2 cases (0.95%) were observed in the non-premedication group. The odds ratio for the occurrence of hypersensitivity reactions in the premedication group was 3.500 (95% confidence interval, 0.727-16.848), with no significant difference. Therefore, premedication did not demonstrate the efficacy in preventing acute hypersensitivity reactions induced by nonionic iodine contrast agents. Based on the results of this study and guidelines, a recommendation for premedication was not reached for patients with a history of allergies, including asthma and atopy, as well as those with a history of drug or food allergies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Experiential Pharmacy Practice, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
- Division of Drug Informatics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo 105-8512, Japan.
- Department of Pharmacy, Yokohama City Minato Red Cross Hospital, Yokohama 231-8682, Japan.
- Department of Pharmacy, Kanagawa Prefectural Keiyukai Keiyu Hospital, Yokohama 220-8521, Japan.
Zitieren
APA
Suzuki, S., Imai, S., Omata, A., Kamimura, T., Kizaki, H., Koinuma, T., & Hori, S. (2025). Evaluating the Efficacy of Premedication in Preventing Hypersensitivity Reactions to Nonionic Contrast Agents. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b24-00808
Vancouver
Suzuki S, Imai S, Omata A, Kamimura T, Kizaki H, Koinuma T, et al. Evaluating the Efficacy of Premedication in Preventing Hypersensitivity Reactions to Nonionic Contrast Agents. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b24-00808
BibTeX
@article{Suzuki2025,
author = {Suzuki, Shinya and Imai, Shungo and Omata, Akinori and Kamimura, Tadamasa and Kizaki, Hayato and Koinuma, Takuma and Hori, Satoko},
title = {Evaluating the Efficacy of Premedication in Preventing Hypersensitivity Reactions to Nonionic Contrast Agents},
journal = {Biological and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/bpb.b24-00808}
}
EUVIMED